To provide a medicine eliciting production of antibody exhibiting complement-mediated bactericidal activity and/or opsonic activity against Neisseria meningitidis serogroup B bacterium.
Molecular mimetics of a surface-exposed epitope on loop 4 of PorA of N. meningitidis serogroup B (MenB) P1.2 serosubtype and antibodies produced against the mimetics are disclosed. Peptide GNA33 containing the amino sequence QTP is also disclosed. The peptide can induce production of antibodies eliciting complement-mediated bactericidal activity and/or opsonic activity against Neisseria meningitidis serogroup B bacterium. Compositions containing such molecular mimetics or the antibodies thereto can be used to prevent MenB disease, as well as for diagnosis of MenB infection.
MOE GREGORY
RAPPUOLI RINO
CHILDRENS HOSP OAK RES INST (US)
Takaaki Yasumura
Natsuki Morishita
Next Patent: METHOD OF PRODUCING FINE CHEMICAL MATERIAL BY FERMENTATION